Skip to main navigation Skip to search Skip to main content

Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer

  • Heba Alkhatib
  • , Jason Conage-Pough
  • , Sangita Roy Chowdhury
  • , Denen Shian
  • , Deema Zaid
  • , Ariel M. Rubinstein
  • , Amir Sonnenblick
  • , Tamar Peretz-Yablonsky
  • , Avital Granit
  • , Einat Carmon
  • , Ishwar N. Kohale
  • , Judy C. Boughey
  • , Matthew P. Goetz
  • , Liewei Wang
  • , Forest M. White*
  • , Nataly Kravchenko-Balasha*
  • *Corresponding author for this work
  • Hebrew University of Jerusalem
  • Massachusetts Institute of Technology
  • Tel Aviv Sourasky Medical Center
  • Hadassah University Medical Centre
  • Assuta Ashdod Hospital
  • Mayo Clinic Rochester, MN
  • Mayo Clinic College of Medicine and Science

Research output: Contribution to journal › Letter › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology